Amyloid beta-peptide Binding Alcohol Dehydrogenase (ABAD) is a novel intracellular enzyme localized in endoplasmic reticulum (ER) and mitochondria with properties of a beta-hydroxyacyl-Co-enzyme A dehydrogenase and a generalized alcohol dehydrogenase. ABAD interacts with amyloid beta-peptide (Abeta), a product of cellular processing of the beta-amyloid precursor protein (APP). Recombinant human ABAD binds Abeta (1-40-42) specifically, via the N-terminus (residues 1-20). ABAD functions as a cofactor in Abeta-induced cell stress; co-transfection of cells with constructs driving over-expression of APP(V717G) and wild- type (wt) ABAD caused generation of reactive aldehydes and induction of DNA fragmentation in COS and neuroblastoma cells. In contrast, similar co-transfection studies with constructs encoding APP(V717G) and mutationally-inactivated ABAD(168/K17G) did not result in cytotoxicity. Furthermore, levels of ABAD are increased in neurons in AD brain, especially those near deposits of Abeta. We propose that enzymatically active ABAD is a critical intracellular target potentiating Abeta-mediated cellular perturbation at the earliest stages of AD; in the endoplasmic reticulum, ABAD interacts with newly formed Abeta(1-42), and the resulting ABAD-Abeta complex generates cellular oxidant resulting in reactive aldehyde formation and induction of DNA fragmentation. The first specific aim is to analyze ABAD-Abeta interaction by structural techniques, exploiting our observation that Abeta(1-20), the latter not prone to aggregation and suitable for structural studies, bind ABAD similarly to full-length Abeta. Co-crystallization of ABAD and Abeta(1- 20) has already produced diffractable crystals.
Our second aim i s to determine mechanisms underlying ABAD-Abeta interaction in a cellular context based on insights from the structural studies. We hypothesize that two salient features of ABAD facilitate of ABAD facilitate potentiation of Abeta-mediated cell stress: localization of ABAD to the ER, where Abeta(1-42) is formed, at least in part; and determinants in ABAD mediating the binding to Abeta. Project 4 will work closely with Projects 1-3, and will, and will obtain technical assistance from Core B. Collaborative interactions we will include: sharing of reagents for analysis of ABAD (Project 3), mechanisms for evaluating for evaluating cell stress (Projects 1-3), and assistance in characterization of mutant ABAD molecules (Core B).

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG017490-01A1
Application #
6310403
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2000-09-01
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Juranek, Judyta K; Daffu, Gurdip K; Geddis, Matthew S et al. (2016) Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. Front Cell Neurosci 10:117
Carlson, Emily A; Marquez, Rebecca T; Du, Fang et al. (2015) Overexpression of 17?-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death. BMC Cancer 15:166
Du, Heng; Guo, Lan; Wu, Xiaoping et al. (2014) Cyclophilin D deficiency rescues A?-impaired PKA/CREB signaling and alleviates synaptic degeneration. Biochim Biophys Acta 1842:2517-27
Juranek, Judyta K; Geddis, Matthew S; Rosario, Rosa et al. (2013) Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE. Eur J Neurosci 38:3159-68
Borger, Eva; Aitken, Laura; Du, Heng et al. (2013) Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? Curr Alzheimer Res 10:21-9
Juranek, Judyta K; Geddis, Matthew S; Song, Fei et al. (2013) RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 62:931-43
Du, Heng; Guo, Lan; Yan, Shirley ShiDu (2012) Synaptic mitochondrial pathology in Alzheimer's disease. Antioxid Redox Signal 16:1467-75
Huang, Tianwen; Fang, Fang; Chen, Limin et al. (2012) Ginsenoside Rg1 attenuates oligomeric A?(1-42)-induced mitochondrial dysfunction. Curr Alzheimer Res 9:388-95
Carnevale, Daniela; Mascio, Giada; D'Andrea, Ivana et al. (2012) Hypertension induces brain ?-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension 60:188-97
Yan, Shirley ShiDu; Chen, Doris; Yan, Shiqian et al. (2012) RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease. Front Biosci (Schol Ed) 4:240-50

Showing the most recent 10 out of 68 publications